116 related articles for article (PubMed ID: 16894287)
1. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications.
Fisher SG; Fisher RI
Curr Opin Oncol; 2006 Sep; 18(5):417-24. PubMed ID: 16894287
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of non-Hodgkin's lymphoma.
Fisher SG; Fisher RI
Oncogene; 2004 Aug; 23(38):6524-34. PubMed ID: 15322522
[TBL] [Abstract][Full Text] [Related]
3. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
5. Host immune response in B-cell lymphomas: friend or foe?
Juszczyński P; Nowak J; Warzocha K
Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and etiology of non-Hodgkin lymphoma--a review.
Ekström-Smedby K
Acta Oncol; 2006; 45(3):258-71. PubMed ID: 16644568
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics.
Chua I; Quinti I; Grimbacher B
Curr Opin Hematol; 2008 Jul; 15(4):368-74. PubMed ID: 18536576
[TBL] [Abstract][Full Text] [Related]
8. Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph.
Becker N; de Sanjose S; Nieters A; Maynadié M; Foretova L; Cocco PL; Staines A; Alvaro T; Vornanen M; Brennan P; Boffetta P
Leuk Res; 2007 Oct; 31(10):1365-72. PubMed ID: 17481729
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis: immunopathogenesis and controversies in defining the cause.
Holmøy T; Hestvik AL
Curr Opin Infect Dis; 2008 Jun; 21(3):271-8. PubMed ID: 18448972
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative disease of the orbit.
Bernardini FP; Bazzan M
Curr Opin Ophthalmol; 2007 Sep; 18(5):398-401. PubMed ID: 17700233
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
[TBL] [Abstract][Full Text] [Related]
15. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
Nieters A; Beckmann L; Deeg E; Becker N
Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
[TBL] [Abstract][Full Text] [Related]
16. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic lymphoma: epidemiology and pathogenesis.
Sjö LD
Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of peripheral T-cell lymphomas.
O'leary H; Savage KJ
Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
Mittal S; Marshall NA; Barker RN; Vickers MA
Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
[TBL] [Abstract][Full Text] [Related]
20. Viruses and lymphoma.
Gandhi MK; Khanna R
Pathology; 2005 Dec; 37(6):420-33. PubMed ID: 16373225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
